Biology and therapeutic potential of hydrogen sulfide and hydrogen sulfide-releasing chimeras

Biochemical Pharmacology

Volumn 85, Issue 5, 2013, Pages 689-703

  Kashfi, Khosrow ^a   Olson, Kenneth R ^b  

^a CITY UNIVERSITY OF NEW YORK MEDICAL SCHOOL   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer prevention; Cardiovascular; Hydrogen sulfide; Inflammation; NSAIDs

Indexed keywords

ACETYLSALICYLIC ACID; ANTINEOPLASTIC AGENT; CYSTEINE DERIVATIVE; DICLOFENAC; ERUCIN; GYY 4137; HYDROGEN SULFIDE; IBUPROFEN; INDOMETACIN; LEVODOPA; MESALAZINE; NAPROXEN; NITRIC OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; SILDENAFIL; SULFORAPHANE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; BIOSYNTHESIS; CHEMISTRY; CHEMOPROPHYLAXIS; CHIMERA; DRUG METABOLISM; GARLIC; HUMAN; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHEMOPREVENTION; CHIMERA; HUMANS; HYDROGEN SULFIDE; NEOPLASMS;

EID: 84873410143     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2012.10.019     Document Type: Review

References (136)

1. K. Abe, and H. Kimura The possible role of hydrogen sulfide as an endogenous neuromodulator J Neurosci 16 1996 1066 1071
2. M.N. Hughes, M.N. Centelles, and K.P. Moore Making and working with hydrogen sulfide: The chemistry and generation of hydrogen sulfide in vitro and its measurement in vivo: a review Free Radic Biol Med 47 2009 1346 1353
3. K.R. Olson The therapeutic potential of hydrogen sulfide: separating hype from hope Am J Physiol Regul Integr Comp Physiol 301 2011 R297 R312
4. K.Y. Chen, and J.C. Morris Oxidation of sulfide by O2: catalysis and inhibition J Sanit Eng Div 98 1972 215 227
5. E.R. DeLeon, G.F. Stoy, and K.R. Olson Passive loss of hydrogen sulfide in biological experiments Anal Biochem 421 2012 203 207
6. X. Shen, C.B. Pattillo, S. Pardue, S.C. Bir, R. Wang, and C.G. Kevil Measurement of plasma hydrogen sulfide in vivo and in vitro Free Radic Biol Med 50 2011 1021 1031
7. E.A. Wintner, T.L. Deckwerth, W. Langston, A. Bengtsson, D. Leviten, and P. Hill A monobromobimane-based assay to measure the pharmacokinetic profile of reactive sulphide species in blood Br J Pharmacol 160 2010 941 957
8. J. Furne, A. Saeed, and M.D. Levitt Whole tissue hydrogen sulfide concentrations are orders of magnitude lower than presently accepted values Am J Physiol Regul Integr Comp Physiol 295 2008 R1479 R1485
9. M.D. Levitt, M.S. Abdel-Rehim, and J. Furne Free and acid-labile hydrogen sulfide concentrations in mouse tissues: anomalously high free hydrogen sulfide in aortic tissue Antioxid Redox Signal 15 2011 373 378
10. N.L. Whitfield, E.L. Kreimier, F.C. Verdial, N. Skovgaard, and K.R. Olson Reappraisal of H2S/sulfide concentration in vertebrate blood and its potential significance in ischemic preconditioning and vascular signaling Am J Physiol Regul Integr Comp Physiol 294 2008 R1930 R1937
11. K.R. Olson Is hydrogen sulfide a circulating gasotransmitter in vertebrate blood Biochim Biophys Acta 1787 2009 856 863
12. T. Ubuka Assay methods and biological roles of labile sulfur in animal tissues J Chromatogr B Analyt Technol Biomed Life Sci 781 2002 227 249
13. K.R. Olson, and N.L. Whitfield Hydrogen sulfide and oxygen sensing in the cardiovascular system Antioxid Redox Signal 12 2010 1219 1234
14. X.C. Wu, W.J. Zhang, D.Q. Wu, R. Sammynaiken, R. Wang, and Q. Yang Using carbon nanotubes to absorb low-concentration hydrogen sulfide in fluid IEEE Trans Nanobioscience 5 2006 204 209
15. A.R. Lippert, E.J. New, and C.J. Chang Reaction-based fluorescent probes for selective imaging of hydrogen sulfide in living cells J Am Chem Soc 133 2011 10078 10080
16. M.H. Stipanuk Sulfur amino acid metabolism: pathways for production and removal of homocysteine and cysteine Annu Rev Nutr 24 2004 539 577
17. Y. Mikami, N. Shibuya, Y. Kimura, N. Nagahara, Y. Ogasawara, and H. Kimura Thioredoxin and dihydrolipoic acid are required for 3-mercaptopyruvate sulfurtransferase to produce hydrogen sulfide Biochem J 439 2011 479 485
18. M. Ishigami, K. Hiraki, K. Umemura, Y. Ogasawara, K. Ishii, and H. Kimura A source of hydrogen sulfide and a mechanism of its release in the brain Antioxid Redox Signal 11 2009 205 214
19. N. Shibuya, M. Tanaka, M. Yoshida, Y. Ogasawara, T. Togawa, and K. Ishii 3-Mercaptopyruvate sulfurtransferase produces hydrogen sulfide and bound sulfane sulfur in the brain Antioxid Redox Signal 11 2009 703 714
20. T. Chiku, D. Padovani, W. Zhu, S. Singh, V. Vitvitsky, and R. Banerjee H2S biogenesis by human cystathionine gamma-lyase leads to the novel sulfur metabolites lanthionine and homolanthionine and is responsive to the grade of hyperhomocysteinemia J Biol Chem 284 2009 11601 11612
21. O. Kabil, and R. Banerjee Redox biochemistry of hydrogen sulfide J Biol Chem 285 2010 21903 21907
22. S. Singh, D. Padovani, R.A. Leslie, T. Chiku, and R. Banerjee Relative contributions of cystathionine beta-synthase and gamma-cystathionase to H2S biogenesis via alternative trans-sulfuration reactions J Biol Chem 284 2009 22457 22466
23. M.H. Stipanuk, and I. Ueki Dealing with methionine/homocysteine sulfur: cysteine metabolism to taurine and inorganic sulfur J Inherit Metab Dis 34 2011 17 32
24. W. Yuan, and J.L. Edwards Thiol metabolomics of endothelial cells using capillary liquid chromatography mass spectrometry with isotope coded affinity tags J Chromatogr A 1218 2011 2561 2568
25. P. Kamoun Endogenous production of hydrogen sulfide in mammals Amino Acids 26 2004 243 254
26. H. Kimura Hydrogen sulfide: its production, release and functions Amino Acids 41 2011 113 121
27. K.R. Olson, N.L. Whitfield, S.E. Bearden, J. St Leger, E. Nilson, and Y. Gao Hypoxic pulmonary vasodilation: a paradigm shift with a hydrogen sulfide mechanism Am J Physiol Regul Integr Comp Physiol 298 2010 R51 R60
28. M. Whiteman, S. Le Trionnaire, M. Chopra, B. Fox, and J. Whatmore Emerging role of hydrogen sulfide in health and disease: critical appraisal of biomarkers and pharmacological tools Clin Sci (Lond) 121 2011 459 488
29. O. Kabil, V. Vitvitsky, P. Xie, and R. Banerjee The quantitative significance of the transsulfuration enzymes for H2S production in murine tissues Antioxid Redox Signal 15 2011 363 372
30. S.E. Bearden, R.S. Beard Jr., and J.C. Pfau Extracellular transsulfuration generates hydrogen sulfide from homocysteine and protects endothelium from redox stress Am J Physiol Heart Circ Physiol 299 2010 H1568 H1576
31. R. Banerjee, and C.G. Zou Redox regulation and reaction mechanism of human cystathionine-beta-synthase: a PLP-dependent hemesensor protein Arch Biochem Biophys 433 2005 144 156
32. Y. Mikami, N. Shibuya, Y. Kimura, N. Nagahara, M. Yamada, and H. Kimura Hydrogen sulfide protects the retina from light-induced degeneration by the modulation of Ca2+ influx J Biol Chem 286 2011 39379 39386
33. C. Szabo Hydrogen sulphide and its therapeutic potential Nat Rev Drug Discov 6 2007 917 935
34. D. Julian, J.L. Statile, S.E. Wohlgemuth, and A.J. Arp Enzymatic hydrogen sulfide production in marine invertebrate tissues Comp Biochem Physiol A Mol Integr Physiol 133 2002 105 115
35. Y. Liang, D. Liu, T. Ochs, C. Tang, S. Chen, and S. Zhang Endogenous sulfur dioxide protects against isoproterenol-induced myocardial injury and increases myocardial antioxidant capacity in rats Lab Invest 91 2011 12 23
36. M.F. Yu, I. Gorenne, X. Su, R.S. Moreland, and M.I. Kotlikoff Sodium hydrosulfite contractions of smooth muscle are calcium and myosin phosphorylation independent Am J Physiol 275 1998 L976 L982
37. K. Wetzelberger, S.P. Baba, M. Thirunavukkarasu, Y.S. Ho, N. Maulik, and O.A. Barski Postischemic deactivation of cardiac aldose reductase: role of glutathione S-transferase P and glutaredoxin in regeneration of reduced thiols from sulfenic acids J Biol Chem 285 2010 26135 26148
38. T.M. Hildebrandt, and M.K. Grieshaber Three enzymatic activities catalyze the oxidation of sulfide to thiosulfate in mammalian and invertebrate mitochondria FEBS J 275 2008 3352 3361
39. E. Lagoutte, S. Mimoun, M. Andriamihaja, C. Chaumontet, F. Blachier, and F. Bouillaud Oxidation of hydrogen sulfide remains a priority in mammalian cells and causes reverse electron transfer in colonocytes Biochim Biophys Acta 1797 2010 1500 1511
40. F. Bouillaud, and F. Blachier Mitochondria and sulfide: a very old story of poisoning, feeding, and signaling Antioxid Redox Signal 15 2011 379 391
41. T.M. Hildebrandt Modulation of sulfide oxidation and toxicity in rat mitochondria by dehydroascorbic acid Biochim Biophys Acta 1807 2011 1206 1213
42. G. Caliendo, G. Cirino, V. Santagada, and J.L. Wallace Synthesis and biological effects of hydrogen sulfide (H2S): development of H2S-releasing drugs as pharmaceuticals J Med Chem 53 2010 6275 6286
43. S. Fiorucci, and L. Santucci Hydrogen sulfide-based therapies: focus on H2S releasing NSAIDs Inflamm Allergy Drug Targets 10 2011 133 140
44. A. Martelli, L. Testai, M.C. Breschi, C. Blandizzi, A. Virdis, and S. Taddei Hydrogen sulphide: novel opportunity for drug discovery Med Res Rev 2010
45. G.L. Bannenberg, and H.L. Vieira Therapeutic applications of the gaseous mediators carbon monoxide and hydrogen sulfide Expert Opin Ther Pat 19 2009 663 682
46. Q.H. Gong, X.R. Shi, Z.Y. Hong, L.L. Pan, X.H. Liu, and Y.Z. Zhu A new hope for neurodegeneration: possible role of hydrogen sulfide J Alzheimers Dis 24 Suppl 2 2011 173 182
47. H. Kimura Hydrogen sulfide: from brain to gut Antioxid Redox Signal 12 2010 1111 1123
48. A.L. King, and D.J. Lefer Cytoprotective actions of hydrogen sulfide in ischaemia-reperfusion injury Exp Physiol 96 2011 840 846
49. L. Li, P. Rose, and P.K. Moore Hydrogen sulfide and cell signaling Annu Rev Pharmacol Toxicol 51 2011 169 187
50. C. Liu, W. Guo, X. Shi, M.A. Kaium, X. Gu, and Y.Z. Zhu Leonurine-cysteine analog conjugates as a new class of multifunctional anti-myocardial ischemia agent Eur J Med Chem 46 2011 3996 4009
51. B.H. Tan, P.T. Wong, and J.S. Bian Hydrogen sulfide: a novel signaling molecule in the central nervous system Neurochem Int 56 2010 3 10
52. M. Whiteman, and P.G. Winyard Hydrogen sulfide and inflammation: the good, the bad, the ugly and the promising Expert Rev Clin Pharmacol 4 2011 13 32
53. M. Derwall, R.C. Francis, K. Kida, M. Bougaki, E. Crimi, and C. Adrie Administration of hydrogen sulfide via extracorporeal membrane lung ventilation in sheep with partial cardiopulmonary bypass perfusion: a proof of concept study on metabolic and vasomotor effects Crit Care 15 2011 R51
54. M.A. Insko, T.L. Deckwerth, P. Hill, C.F. Toombs, and C. Szabo Detection of exhaled hydrogen sulphide gas in rats exposed to intravenous sodium sulphide Br J Pharmacol 157 2009 944 951
55. C.F. Toombs, M.A. Insko, E.A. Wintner, T.L. Deckwerth, H. Usansky, and K. Jamil Detection of exhaled hydrogen sulphide gas in healthy human volunteers during intravenous administration of sodium sulphide Br J Clin Pharmacol 69 2010 626 636
56. C.H. Kaschula, R. Hunter, H.T. Hassan, N. Stellenboom, J. Cotton, and X.Q. Zhai Anti-proliferation activity of synthetic ajoene analogues on cancer cell-lines Anticancer Agents Med Chem 11 2011 260 266
57. G.A. Benavides, G.L. Squadrito, R.W. Mills, H.D. Patel, T.S. Isbell, and R.P. Patel Hydrogen sulfide mediates the vasoactivity of garlic Proc Natl Acad Sci USA 104 2007 17977 17982
58. G. Sener, A. Sakarcan, and B.C. Yegen Role of garlic in the prevention of ischemia-reperfusion injury Mol Nutr Food Res 51 2007 1345 1352
59. A. Tsubura, Y.C. Lai, M. Kuwata, N. Uehara, and K. Yoshizawa Anticancer effects of garlic and garlic-derived compounds for breast cancer control Anticancer Agents Med Chem 11 2011 249 253
60. R. Padiya, T.N. Khatua, P.K. Bagul, M. Kuncha, and S.K. Banerjee Garlic improves insulin sensitivity and associated metabolic syndromes in fructose fed rats Nutr Metab (Lond) 8 2011 53
61. L. Ye, A.T. Dinkova-Kostova, K.L. Wade, Y. Zhang, T.A. Shapiro, and P. Talalay Quantitative determination of dithiocarbamates in human plasma, serum, erythrocytes and urine: pharmacokinetics of broccoli sprout isothiocyanates in humans Clin Chim Acta 316 2002 43 53
62. S.J. Jackson, K.W. Singletary, and R.C. Venema Sulforaphane suppresses angiogenesis and disrupts endothelial mitotic progression and microtubule polymerization Vascul Pharmacol 46 2007 77 84
63. Y. Shan, R. Zhao, W. Geng, N. Lin, X. Wang, and X. Du Protective effect of sulforaphane on human vascular endothelial cells against lipopolysaccharide- induced inflammatory damage Cardiovasc Toxicol 10 2010 139 145
64. H. Zhu, Z. Jia, J.S. Strobl, M. Ehrich, H.P. Misra, and Y. Li Potent induction of total cellular and mitochondrial antioxidants and phase 2 enzymes by cruciferous sulforaphane in rat aortic smooth muscle cells: cytoprotection against oxidative and electrophilic stress Cardiovasc Toxicol 8 2008 115 125
65. S. Mukherjee, I. Lekli, D. Ray, H. Gangopadhyay, U. Raychaudhuri, and D.K. Das Comparison of the protective effects of steamed and cooked broccolis on ischaemia-reperfusion-induced cardiac injury Br J Nutr 103 2010 815 823
66. V. Calabrese, C. Cornelius, A.T. Dinkova-Kostova, E.J. Calabrese, and M.P. Mattson Cellular stress responses, the hormesis paradigm, and vitagenes: novel targets for therapeutic intervention in neurodegenerative disorders Antioxid Redox Signal 13 2010 1763 1811
67. L. Li, M. Whiteman, Y.Y. Guan, K.L. Neo, Y. Cheng, and S.W. Lee Characterization of a novel, water-soluble hydrogen sulfide-releasing molecule (GYY4137): new insights into the biology of hydrogen sulfide Circulation 117 2008 2351 2360
68. Z.W. Lee, J. Zhou, C.S. Chen, Y. Zhao, C.H. Tan, and L. Li The slow-releasing hydrogen sulfide donor, GYY4137, exhibits novel anti-cancer effects in vitro and in vivo PLoS One 6 2011 e21077
69. F. Yu, J. Zhao, C.S. Tang, and B. Geng [Effect of synthesized GYY4137, a slowly releasing hydrogen sulfide donor, on cell viability and distribution of hydrogen sulfide in mice] Beijing Da Xue Xue Bao 42 2010 493 497
70. Q.C. Yong, J.L. Cheong, F. Hua, L.W. Deng, Y.M. Khoo, and H.S. Lee Regulation of heart function by endogenous gaseous mediators-crosstalk between nitric oxide and hydrogen sulfide Antioxid Redox Signal 14 2011 2081 2091
71. L. Li, M. Salto-Tellez, C.H. Tan, M. Whiteman, and P.K. Moore GYY4137, a novel hydrogen sulfide-releasing molecule, protects against endotoxic shock in the rat Free Radic Biol Med 47 2009 103 113
72. J.L. Wallace, M. Dicay, W. McKnight, and G.R. Martin Hydrogen sulfide enhances ulcer healing in rats FASEB J 21 2007 4070 4076
73. Q. Wang, X.L. Wang, H.R. Liu, P. Rose, and Y.Z. Zhu Protective effects of cysteine analogues on acute myocardial ischemia: novel modulators of endogenous H(2)S production Antioxid Redox Signal 12 2010 1155 1165
74. Q.H. Gong, Q. Wang, L.L. Pan, X.H. Liu, H. Xin, and Y.Z. Zhu S-propargyl-cysteine, a novel hydrogen sulfide-modulated agent, attenuates lipopolysaccharide-induced spatial learning and memory impairment: involvement of TNF signaling and NF-kappaB pathway in rats Brain Behav Immun 25 2011 110 119
75. S.C. Chuah, P.K. Moore, and Y.Z. Zhu S-allylcysteine mediates cardioprotection in an acute myocardial infarction rat model via a hydrogen sulfide-mediated pathway Am J Physiol Heart Circ Physiol 293 2007 H2693 H2701
76. C. Liu, X. Gu, and Y.Z. Zhu Synthesis and biological evaluation of novel leonurine-SPRC conjugate as cardioprotective agents Bioorg Med Chem Lett 20 2010 6942 6946
77. K. Ma, Y. Liu, Q. Zhu, C.H. Liu, J.L. Duan, and B.K. Tan H2S donor, S-propargyl-cysteine, increases CSE in SGC-7901 and cancer-induced mice: evidence for a novel anti-cancer effect of endogenous H2S? PLoS One 6 2011 e20525
78. L.L. Pan, X.H. Liu, Q.H. Gong, and Y.Z. Zhu S-Propargyl-cysteine (SPRC) attenuated lipopolysaccharide-induced inflammatory response in H9c2 cells involved in a hydrogen sulfide-dependent mechanism Amino Acids 41 2011 205 215
79. J.I. Toohey Sulfur metabolism in AIDS: cystamine as an anti-HIV agent AIDS Res Hum Retroviruses 25 2009 1057 1060
80. J.I. Toohey Persulfide sulfur is a growth factor for cells defective in sulfur metabolism Biochem Cell Biol 64 1986 758 765
81. Y. Zhao, H. Wang, and M. Xian Cysteine-activated hydrogen sulfide (H2S) donors J Am Chem Soc 133 2011 15 17
82. M. Lee, V. Tazzari, D. Giustarini, R. Rossi, A. Sparatore, and P. Del Soldato Effects of hydrogen sulfide-releasing L-DOPA derivatives on glial activation: potential for treating Parkinson disease J Biol Chem 285 2010 17318 17328
83. A. Sparatore, E. Perrino, V. Tazzari, D. Giustarini, R. Rossi, and G. Rossoni Pharmacological profile of a novel H(2)S-releasing aspirin Free Radic Biol Med 46 2009 586 592
84. D. Giustarini, P. Del Soldato, A. Sparatore, and R. Rossi Modulation of thiol homeostasis induced by H2S-releasing aspirin Free Radic Biol Med 48 2010 1263 1272
85. M. Lee, A. Sparatore, P. Del Soldato, E. McGeer, and P.L. McGeer Hydrogen sulfide-releasing NSAIDs attenuate neuroinflammation induced by microglial and astrocytic activation Glia 58 2010 103 113
86. S. Muzaffar, J.Y. Jeremy, A. Sparatore, P. Del Soldato, G.D. Angelini, and N. Shukla H2S-donating sildenafil (ACS6) inhibits superoxide formation and gp91phox expression in arterial endothelial cells: role of protein kinases A and G Br J Pharmacol 155 2008 984 994
87. L. Li, G. Rossoni, A. Sparatore, L.C. Lee, P. Del Soldato, and P.K. Moore Anti-inflammatory and gastrointestinal effects of a novel diclofenac derivative Free Radic Biol Med 42 2007 706 719
88. L. Lazzarato, K. Chegaev, E. Marini, B. Rolando, E. Borretto, and S. Guglielmo New nitric oxide or hydrogen sulfide releasing aspirins J Med Chem 54 2011 5478 5484
89. G. Rossoni, B. Manfredi, V. Tazzari, A. Sparatore, S. Trivulzio, and P. Del Soldato Activity of a new hydrogen sulfide-releasing aspirin (ACS14) on pathological cardiovascular alterations induced by glutathione depletion in rats Eur J Pharmacol 648 2010 139 145
90. N. Shukla, G. Rossoni, M. Hotston, A. Sparatore, P. Del Soldato, and V. Tazzari Effect of hydrogen sulphide-donating sildenafil (ACS6) on erectile function and oxidative stress in rabbit isolated corpus cavernosum and in hypertensive rats BJU Int 103 2009 1522 1529
91. G. Rossoni, A. Sparatore, V. Tazzari, B. Manfredi, P. Del Soldato, and F. Berti The hydrogen sulphide-releasing derivative of diclofenac protects against ischaemia-reperfusion injury in the isolated rabbit heart Br J Pharmacol 153 2008 100 109
92. R. Baskar, A. Sparatore, P. Del Soldato, and P.K. Moore Effect of S-diclofenac, a novel hydrogen sulfide releasing derivative inhibit rat vascular smooth muscle cell proliferation Eur J Pharmacol 594 2008 1 8
93. Y.Y. Liu, A. Sparatore, P. Del Soldato, and J.S. Bian ACS84, a novel hydrogen sulfide-releasing compound, protects against amyloid beta-induced cell cytotoxicity Neurochem Int 58 2011 591 598
94. Y.Y. Liu, A. Sparatore, P. Del Soldato, and J.S. Bian H2S releasing aspirin protects amyloid beta induced cell toxicity in BV-2 microglial cells Neuroscience 193 2011 80 88
95. M. Bhatia, J. Sidhapuriwala, S.M. Moochhala, and P.K. Moore Hydrogen sulphide is a mediator of carrageenan-induced hindpaw oedema in the rat Br J Pharmacol 145 2005 141 144
96. L. Li, M. Bhatia, Y.Z. Zhu, Y.C. Zhu, R.D. Ramnath, and Z.J. Wang Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced inflammation in the mouse Faseb J 19 2005 1196 1198
97. F. Anuar, M. Whiteman, M. Bhatia, and P.K. Moore Flurbiprofen and its nitric oxide-releasing derivative protect against septic shock in rats Inflamm Res 55 2006 498 503
98. F. Anuar, M. Whiteman, J.L. Siau, S.E. Kwong, M. Bhatia, and P.K. Moore Nitric oxide-releasing flurbiprofen reduces formation of proinflammatory hydrogen sulfide in lipopolysaccharide-treated rat Br J Pharmacol 147 2006 966 974
99. M. Bhatia, F.L. Wong, D. Fu, H.Y. Lau, S.M. Moochhala, and P.K. Moore Role of hydrogen sulfide in acute pancreatitis and associated lung injury Faseb J 19 2005 623 625
100. R. Tamizhselvi, P.K. Moore, and M. Bhatia Hydrogen sulfide acts as a mediator of inflammation in acute pancreatitis: in vitro studies using isolated mouse pancreatic acinar cells J Cell Mol Med 11 2007 315 326
101. R.C. Zanardo, V. Brancaleone, E. Distrutti, S. Fiorucci, G. Cirino, and J.L. Wallace Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation Faseb J 20 2006 2118 2120
102. M.A. Mariggio, V. Minunno, S. Riccardi, R. Santacroce, P. De Rinaldis, and R. Fumarulo Sulfide enhancement of PMN apoptosis Immunopharmacol Immunotoxicol 20 1998 399 408
103. D.W. Gilroy, T. Lawrence, M. Perretti, and A.G. Rossi Inflammatory resolution: new opportunities for drug discovery Nat Rev Drug Discov 3 2004 401 416
104. D.J. Bjorkman Current status of nonsteroidal anti-inflammatory drug (NSAID) use in the United States: risk factors and frequency of complications Am J Med 107 1999 3S 8S discussion S-10S
105. J.L. Wallace Prostaglandins, NSAIDs, and gastric mucosal protection: why doesn't the stomach digest itself Physiol Rev 88 2008 1547 1565
106. S. Okabe, and K. Amagase An overview of acetic acid ulcer models - the history and state of the art of peptic ulcer research Biol Pharm Bull 28 2005 1321 1341
107. J.L. Wallace, G. Caliendo, V. Santagada, G. Cirino, and S. Fiorucci Gastrointestinal safety and anti-inflammatory effects of a hydrogen sulfide-releasing diclofenac derivative in the rat Gastroenterology 132 2007 261 271
108. J.L. Wallace Hydrogen sulfide-releasing anti-inflammatory drugs Trends Pharmacol Sci 28 2007 501 505
109. S. Fiorucci, S. Orlandi, A. Mencarelli, G. Caliendo, V. Santagada, and E. Distrutti Enhanced activity of a hydrogen sulphide-releasing derivative of mesalamine (ATB-429) in a mouse model of colitis Br J Pharmacol 150 2007 996 1002
110. J.L. Wallace, G. Caliendo, V. Santagada, and G. Cirino Markedly reduced toxicity of a hydrogen sulphide-releasing derivative of naproxen (ATB-346) Br J Pharmacol 159 2010 1236 1246
111. R.B. Sartor Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases Am J Gastroenterol 92 1997 5S 11S
112. A. Stallmach, B. Wittig, T. Giese, K. Pfister, J.C. Hoffmann, and S. Bulfone-Paus Protection of trinitrobenzene sulfonic acid-induced colitis by an interleukin 2-IgG2b fusion protein in mice Gastroenterology 117 1999 866 876
113. M.N. Ajuebor, C.M. Hogaboam, S.L. Kunkel, A.E. Proudfoot, and J.L. Wallace The chemokine RANTES is a crucial mediator of the progression from acute to chronic colitis in the rat J Immunol 166 2001 552 558
114. G.P. Morris, P.L. Beck, M.S. Herridge, W.T. Depew, M.R. Szewczuk, and J.L. Wallace Hapten-induced model of chronic inflammation and ulceration in the rat colon Gastroenterology 96 1989 795 803
115. Fiorucci S, PB, Mencarelli A, Fanini C, Morelli A, Del Soldato P. NO-aspirin (NCX4016) modulates pro-inflammatory cytokines and COX isoenzymes. An human study. Abstract, 2002.
116. E. Distrutti, L. Sediari, A. Mencarelli, B. Renga, S. Orlandi, and G. Russo 5-Amino-2-hydroxybenzoic acid 4-(5-thioxo-5H-[1,2]dithiol-3yl)-phenyl ester (ATB-429), a hydrogen sulfide-releasing derivative of mesalamine, exerts antinociceptive effects in a model of postinflammatory hypersensitivity J Pharmacol Exp Ther 319 2006 447 458
117. M.J. Thun, S.J. Henley, and C. Patrono Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues J Natl Cancer Inst 94 2002 252 266
118. K. Kashfi Anti-inflammatory agents as cancer therapeutics Adv Pharmacol 57 2009 31 89
119. M. Chattopadhyay, R. Kodela, N. Nath, Y.M. Dastagirzada, C.A. Velazquez-Martinez, and D. Boring Hydrogen sulfide-releasing NSAIDs inhibit the growth of human cancer cells: a general property and evidence of a tissue type-independent effect Biochem Pharmacol 83 2012 715 722
120. M. Chattopadhyay, R. Kodela, N. Nath, A. Barsegian, D. Boring, and K. Kashfi Hydrogen sulfide-releasing aspirin suppresses NF-kappaB signaling in estrogen receptor negative breast cancer cells in vitro and in vivo Biochem Pharmacol 83 2012 723 732
121. D.K. Biswas, S.C. Dai, A. Cruz, B. Weiser, E. Graner, and A.B. Pardee The nuclear factor kappa B (NF-kappa B): a potential therapeutic target for estrogen receptor negative breast cancers Proc Natl Acad Sci USA 98 2001 10386 10391
122. C.H. Switzer, R.Y. Cheng, L.A. Ridnour, M.C. Murray, V. Tazzari, and A. Sparatore Dithiolethiones inhibit NF-kappaB activity via covalent modification in human estrogen receptor-negative breast cancer Cancer Res 72 2012 2394 2404
123. M. Chattopadhyay, R. Kodela, N. Nath, C.R. Street, C.A. Velazquez-Martinez, and D. Boring Hydrogen sulfide-releasing aspirin modulates xenobiotic metabolizing enzymes in vitro and in vivo Biochem Pharmacol 83 2012 733 740
124. J.L. Wallace, and M.J. Miller Nitric oxide in mucosal defense: a little goes a long way Gastroenterology 119 2000 512 520
125. K. Kashfi, and B. Rigas The mechanism of action of nitric oxide-donating aspirin Biochem Biophys Res Commun 358 2007 1096 1101
126. N. Hulsman, J.P. Medema, C. Bos, A. Jongejan, R. Leurs, and M.J. Smit Chemical insights in the concept of hybrid drugs: the antitumor effect of nitric oxide-donating aspirin involves a quinone methide but not nitric oxide nor aspirin J Med Chem 50 2007 2424 2431
127. T. Dunlap, R.E. Chandrasena, Z. Wang, V. Sinha, Z. Wang, and G.R. Thatcher Quinone formation as a chemoprevention strategy for hybrid drugs: balancing cytotoxicity and cytoprotection Chem Res Toxicol 20 2007 1903 1912
128. BioSpace. National Cancer Institute Ends Colon Cancer Trial with NicOx SA (NCOX.F)'s NCX 4016. http://wwwbiospacecom/news-storyaspx?StoryId=60278; 2007.
129. K. Kashfi, S. Borgo, J.L. Williams, J. Chen, J. Gao, and A. Glekas Positional isomerism markedly affects the growth inhibition of colon cancer cells by nitric oxide-donating aspirin in vitro and in vivo J Pharmacol Exp Ther 312 2005 978 988
130. R. Kodela, M. Chattopadhyay, and K. Kashfi NOSH-Aspirin. A Novel Nitric Oxide-Hydrogen Sulfide-Releasing Hybrid: A New Class of Anti-inflammatory Pharmaceuticals ACS Med Chem Lett 3 2012 257 262
131. M. Chattopadhyay, R. Kodela, K.R. Olson, and K. Kashfi NOSH-aspirin (NBS-1120), a novel nitric oxide- and hydrogen sulfide-releasing hybrid is a potent inhibitor of colon cancer cell growth in vitro and in a xenograft mouse model Biochem Biophys Res Commun 419 2012 523 528
132. A. Bilska, M. Iciek, I. Kwiecien, K. Kaniecki, M. Paliborek, and E. Somogyi Effects of aspirin on the levels of hydrogen sulfide and sulfane sulfur in mouse tissues Pharmacol Rep 62 2010 304 310
133. B. Wilinski, J. Wilinski, E. Somogyi, M. Goralska, and J. Piotrowska Paracetamol (acetaminophen) decreases hydrogen sulfide tissue concentration in brain but increases it in the heart, liver and kidney in mice Folia Biol (Krakow) 59 2011 41 44
134. B. Wilinski, J. Wilinski, E. Somogyi, J. Piotrowska, and M. Goralska Atorvastatin affects the tissue concentration of hydrogen sulfide in mouse kidneys and other organs Pharmacol Rep 63 2011 184 188
135. G. Wojcicka, A. Jamroz-Wisniewska, P. Atanasova, G.N. Chaldakov, B. Chylinska-Kula, and J. Beltowski Differential effects of statins on endogenous H2S formation in perivascular adipose tissue Pharmacol Res 63 2011 68 76
136. F.N. Salloum, V.Q. Chau, N.N. Hoke, A. Abbate, A. Varma, and R.A. Ockaili Phosphodiesterase-5 inhibitor, tadalafil, protects against myocardial ischemia/reperfusion through protein-kinase g-dependent generation of hydrogen sulfide Circulation 120 2009 S31 S36